Medicare Enrolled

Dr. Victoria Villaflor, M.D.

Medical Oncology · Orange, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
101 THE CITY DR S, Orange, CA 92868
7144568888
In practice since 2006 (20 years)
NPI: 1154380582 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Villaflor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Villaflor? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Villaflor

Dr. Victoria Villaflor is a medical oncology specialist in Orange, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Villaflor performed 766 Medicare services across 294 unique beneficiaries.

Between the years covered by Open Payments, Dr. Villaflor received a total of $89,957 from 23 pharmaceutical and/or device companies across 113 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Villaflor is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 45% volume in CA $89,957 industry payments

Medicare Practice Summary

Medicare Utilization ↗
766
Medicare services
Top 45% in CA for medical oncology
294
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~38 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
598 $120 $380
New patient office visit, complex (60-74 min) 79 $152 $557
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
26 $66 $289
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
22 $63 $276
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
21 $26 $97
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
20 $100 $434
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$89,957
Total received (2018-2024)
Avg $12,851/year across 7 years
Top 15% in CA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
113
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$81,072 (90.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,817 (8.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,068 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,896
2023
$20,279
2022
$154
2021
$3,945
2020
$10,628
2019
$36,405
2018
$13,650

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Coherus Biosciences Inc.
$2,513
Daiichi Sankyo Inc.
$1,875
Deciphera Pharmaceuticals Inc.
$125
Merck Sharp & Dohme LLC
$124
AstraZeneca Pharmaceuticals LP
$95
Gilead Sciences, Inc.
$93
Janssen Biotech, Inc.
$23
Novartis Pharmaceuticals Corporation
$17
E.R. Squibb & Sons, L.L.C.
$17
Eisai Inc.
$14
Top 3 companies account for 92.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$42,867
Regeneron Pharmaceuticals, Inc.
$12,529
Gilead Sciences, Inc.
$7,473
E.R. Squibb & Sons, L.L.C.
$6,898
Genentech, Inc.
$5,815
Novocure Inc.
$5,196
Coherus Biosciences Inc.
$2,513
GENZYME CORPORATION
$1,962
JAZZ PHARMACEUTICALS INC.
$1,920
Daiichi Sankyo Inc.
$1,875
Galvanize Therapeutics, Inc
$198
Deciphera Pharmaceuticals Inc.
$125
Merck Sharp & Dohme LLC
$124
PFIZER INC.
$108
Janssen Scientific Affairs, LLC
$86
Celgene Corporation
$70
Bayer Healthcare Pharmaceuticals Inc.
$65
Smith+Nephew, Inc.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$30
Janssen Biotech, Inc.
$23
Novartis Pharmaceuticals Corporation
$17
Eisai Inc.
$14
Merck Sharp & Dohme Corporation
$10
Top 3 companies account for 69.9% of all-time payments
Associated products mentioned in payments ›
ALIYA SYSTEM · ALUNBRIG · GRAFIX · IMFINZI · KEYTRUDA · LIBTAYO · LOQTORZI · LORBRENA · LUTATHERA · Lenvima · OPDIVO · Oncology · QINLOCK · RYBREVANT · TAGRISSO · TECENTRIQ · Udenyca · Vitrakvi · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for a medical oncology specialist in Orange?
Compare medical oncologists in the Orange area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
57
Per 100K population
1.8
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Villaflor is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 15% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Villaflor experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Villaflor performed 598 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Villaflor receive payments from pharmaceutical companies?
Yes. Dr. Villaflor received a total of $89,957 from 23 companies across 113 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Villaflor's costs compare to other medical oncologists in Orange?
Dr. Villaflor's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Villaflor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →